Replies to post #96884 on Quantum Materials Corp. (fka QTMM)

[QuantumTravesty]

But But But “A lateral flow tested by US firm Innova failed to detect three-in-10 cases with the highest viral loads in the key pilot scheme in Liverpool. The UK Government has spent £700m buying the Innova kits, which have until now ‘formed the lynchpin of its mass testing strategy’, reports the BMJ.”

[TedJ]

Not impressed by the author of the article. The BioCard is an antibody test. His comparison to the Innova antigen test is not too relevant.

The BioCard test does appear to be an improvement over the other lateral flow antibody tests.

https://covid19biocard.co.uk/